Asieris: Data related to the international multicenter Phase III clinical trial of APL-1702 published in the international journal "Med"
I'm PortAI, I can summarize articles.
Asieris announced that the results of its Phase III clinical trial for APL-1702, used for the treatment of high-grade squamous intraepithelial lesions of the cervix, have been published in the international journal "Med." APL-1702 is a photodynamic therapy product that is still in the approval stage, with uncertainties regarding its market launch and commercial prospects. The publication of this data has little impact on the company's recent performance
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments